← Diseases & Conditions · Breast Cancer / PinkPOWER
🎀 My PinkPOWER ClubMy Girl Power™ Series · A4 — Athletes, Artists & Angels in Action
PHIT Score · Women's Health Focus · Fit Family FORCE Challenge Series

National Breast Cancer Overview

What breast cancer is, who it's affecting, and how America's communities stack up — a public dashboard powering the PHIT Score Breast Cancer sub-indicator. Part of the My Girl Power™ Series under A4 — Athletes, Artists & Angels in Action and the Fit Family FORCE Challenge Series: every month we follow the women's Health Awareness calendar and turn it into a Reality Health Games Challenge. Built for partners, providers, and every woman who deserves to know her odds before the diagnosis.

1 in 8
Lifetime risk, US women
310,720
New invasive cases / yr
42,780
US deaths / yr
91%
5-yr survival (localized)
4.3M
US survivors living today
Presented in partnership with the Larry Fitzgerald Foundation — Power Foundational Partner

💪 The My Girl Power™ Series

My PinkPOWER Club is one of five clubs in the My Girl Power™ Series — part of the A4 — Athletes, Artists & Angels in Action initiative and the Fit Family FORCE Challenge Series + Ambassador Challenge. Throughout the year we follow the women's Health Awareness calendar and turn each awareness day into a Reality Health Games Challenge. Join one club, earn your coins, then step up into (STEAM TEAMS)³ to Find Your Inner Athlete.

❤️
My Cardio Girl
Heart Health · In the Series
Join the Challenge →
🎀
My PinkPOWER Club
Breast Cancer · Active
You are here ↑
🔬
My Science Girl
STEM + Health Literacy
Join the Challenge →
🏛️
My Civics Girl
Civic Health & Voice
Join the Challenge →
💰
My Finance Girl
Financial Wellness
Join the Challenge →
🏆
Find Your Inner Athlete
(STEAM TEAMS)³ · Reality Health Games
Level Up →
🗓️ How it works: Every month, the series follows a women's Health Awareness observance — October is Breast Cancer Awareness and My PinkPOWER Club leads. Join the club, play the matching Bingo Card and Reality Health Games Challenge, earn Learn It / Live It / Share It coins, and step into (STEAM TEAMS)³ to Find Your Inner Athlete.

Join a Challenge

The My Girl Power™ Series runs four branded challenges throughout the year as part of the Fit Family FORCE Ambassador Challenge. Pick one, two, or all four. Earn Learn It / Live It / Share It coins, then level up to Find Your Inner Athlete in the Reality Health Games.

📖
Legacy Book Buddy Challenge
Capture your family's health legacy with a buddy — stories, rituals, survivor wisdom, generational lessons. Climb the Personal Publisher ladder from Bronze to Legacy Publisher (a 64-page hardcover book in your name).
Start the Challenge →
🪶
The WingTapper's Challenge
Tap into your community with purpose — a seasonal challenge wrapping movement, mentorship, and micro-acts of awareness into the Girl Power rhythm.
Coming Soon →
🌞
Get Out & About Challenge
Seasonal health in motion — community walks, parks, markets, and neighborhood exploration paired with the Out & About Spring Intro Health overlay.
Coming Soon →
📚
Journey Through Genres Challenge
Read, watch, listen across health-story genres — memoir, documentary, poetry, data. Health literacy as a creative practice across generations.
Coming Soon →

What Is Breast Cancer?

Breast cancer is a disease in which cells in the breast grow out of control. It is not one disease but a family of subtypes, each with its own behavior, treatment, and outlook. Early detection changes the odds — dramatically.

📍 DCIS — Stage 0
Ductal carcinoma in situ. Abnormal cells confined to the milk duct. Very high survival when caught; often found by mammography.
🔬 Invasive Ductal (IDC)
The most common type (~80% of invasive cases). Begins in the duct and spreads into surrounding breast tissue.
🔬 Invasive Lobular (ILC)
~10–15% of cases. Starts in the milk-producing lobules. Often harder to see on mammogram — may require MRI.
⚡ HER2-Positive
About 15–20% of cases. Tumor overproduces the HER2 protein. Aggressive, but highly treatable with targeted therapies (trastuzumab).
⚠️ Triple-Negative (TNBC)
~10–15% of cases. Lacks three common receptors — so hormone and HER2 therapies don't work. More common in Black women and BRCA1 carriers.
🧬 BRCA1 / BRCA2
Inherited mutations that raise lifetime risk to 55–72% (BRCA1) or 45–69% (BRCA2). About 5–10% of breast cancers are hereditary.
🚨 Inflammatory Breast Cancer
Rare (~1–5%) and aggressive. Presents as redness, swelling, and warmth — often mistaken for infection. Usually no distinct lump.
👨 Male Breast Cancer
~2,800 new US cases and ~530 deaths per year. Often diagnosed later because awareness is lower among men and providers.

Who's Getting It?

Breast cancer does not affect everyone equally. Age drives incidence, race and geography drive outcomes, and the disparities are stark.

Median Age at Dx
62
Most US cases are in women 55–74, but ~9% are under 45.
Women ≥ 40 ever screened
76%
BRFSS 2022 — mammogram within past 2 years. Target is 80%.
Black vs White mortality
+40%
Black women are 40% more likely to die from breast cancer despite similar incidence.
TNBC in Black women
2×
Twice as likely to be diagnosed with aggressive triple-negative subtype.
Hispanic/Latina incidence
–32%
Lower incidence than White women, but often diagnosed later and younger.
AI/AN women
+8%
Mortality rate has been rising in American Indian/Alaska Native women while declining in most groups.
AAPI women
+1.5%/yr
Incidence in Asian American / Pacific Islander women rising faster than any other group since 2015.
Rural vs urban mortality
+17%
Rural women have higher breast cancer mortality, driven by screening access and specialist shortages.
BRCA1/2 carriers
1 in 400
In general US population. Prevalence is ~1 in 40 in Ashkenazi Jewish women.
Family history
~15%
Of women with breast cancer have a first-degree relative with the disease.

State-Level Breast Cancer Snapshot Coach LucyCoach Lucy + Sources Coach Lucy on State SnapshotsWhy state ≠ outcome

The state map shows age-adjusted incidence, mortality, and screening rates per 100,000 women. Lower values do not always mean better. A low-incidence state can simply be under-screened — meaning women aren't being diagnosed, but the disease is still there.

Read mortality + screening together. The states with the best outcomes have high screening + low mortality. DC, MA, CT consistently lead. The states to watch are those with high mortality AND low screening — that's where PHIT-funded screening interventions move the needle most.

 📊 Data sources CDC US Cancer Statistics (USCS) NCI SEER Cancer Stat Facts: Female Breast CDC BRFSS — Mammography Rates State Cancer Profiles (NCI + CDC)

Click any state to see its Breast Cancer profile — incidence, mortality, and screening rates. Data from CDC U.S. Cancer Statistics (USCS), SEER, and BRFSS.

Lower
Higher Lower values ≠ better. Low incidence can reflect under-screening; low mortality is the outcome that matters.

Global Incidence Snapshot — WHO GLOBOCAN 2022

Breast cancer is the most diagnosed cancer globally in women: ~2.3M new cases/yr · ~670K deaths/yr. Highest incidence rates in Western Europe + Australia + North America. Lowest rates in Sub-Saharan Africa + South Asia — but mortality is highest in low-income regions due to late-stage diagnosis and screening gaps. Source: WHO GLOBOCAN / IARC 2022.

Show metric:
Coach Lucy
Why is the chart misleading? Hover for the disparity paradox →

Top 10 Countries Globally · Age-Standardized Incidence (per 100K women)

↗ Click any WHO Region card on the right to filter this chart by region.

⭐ The US ranks 5th globally for incidence — but combined with our 91% 5-year survival rate (localized stage), the US story is "high diagnosis, high survival" thanks to widespread mammographic screening.

By WHO Region

👇 Click a region to filter the country chart on the left.

The global disparity story: Breast cancer incidence is highest in high-income countries (better detection) — but mortality is highest in low-income countries. Sub-Saharan Africa: low incidence (~32/100K) but mortality-to-incidence ratio >55% vs. ~14% in the US. The PHIT lesson is that screening + early-stage diagnosis is the lever that closes the survival gap.

Demographic Trends — Race & Age Coach LucyCoach Lucy + Sources Coach Lucy on Race + AgeThe disparity that matters most

Black women have ~3% LOWER incidence than white women — but ~40% HIGHER mortality. That's not biology alone. It's later-stage diagnosis, treatment access, and a higher rate of triple-negative breast cancer (which is more aggressive and less responsive to standard hormone therapy).

The age story is more nuanced. Incidence peaks 60-79 (440/100K) — but the only age band TRENDING UP is under-50. Likely drivers: later first pregnancy, environmental factors, obesity. Standard screening starts at 40 (USPSTF 2024 update) — but ~24/100K under-40 cases means risk awareness needs to start earlier.

Click the metric pills to flip between Incidence / Mortality / 5-Yr Survival. The disparity story is starkest on Mortality.

 📊 Data sources CDC US Cancer Statistics — by race/ethnicity + age SEER — Cancer Stat Facts (age-adjusted) USPSTF Screening Recommendations 2024 ACS Breast Cancer Facts & Figures

Breast cancer does not affect everyone equally. Black women face a 40% higher mortality rate than white women despite lower incidence. Age drives incidence, race + geography drive outcomes. Source: CDC US Cancer Statistics (USCS) + SEER, age-adjusted to 2000 US standard population.

Metric:

By Race / Ethnicity (US, age-adjusted)

The disparity that matters most: Black women have ~3% LOWER incidence than white women but ~40% HIGHER mortality. This gap reflects later-stage diagnosis, treatment access, and biology (Black women have higher rates of triple-negative breast cancer).

By Age Group (US, current)

The early-onset trend: Incidence in women under 50 is rising ~1-2%/yr — the only age band trending up. Reasons unclear but likely include later first pregnancy, environmental factors, and obesity. Standard screening starts at 40 (USPSTF 2024 update) — but ~24/100K under-40 cases means risk awareness needs to start earlier.

10-Year Trend — Annual % Change in Mortality by Race

Mortality is declining for most groups thanks to screening + treatment advances — but the racial gap is closing slowly. Black women's mortality is declining at ~half the rate of white women's.

⚪ White (NH)
−1.0%/yr
↓ Best
⚫ Black
−0.5%/yr
⚠ Half rate
🟫 Hispanic
−1.2%/yr
↓ Strong
🟨 Asian/PI
−0.2%/yr
→ Stable
🟧 AI / AN
±0%
→ Flat

Key Facts

A national snapshot of the burden, the progress, and the gaps.

1 in 8
US women's lifetime risk
~13% chance of invasive breast cancer in a woman's lifetime.
310,720
New invasive cases / yr
Plus ~56,500 new cases of DCIS (Stage 0). ACS 2024 estimate.
42,780
US deaths / yr
Breast cancer is the 2nd leading cause of cancer death in US women (after lung).
91%
5-yr survival, localized
Drops to 86% regional, 31% distant/metastatic. Early detection is everything.
−43%
Mortality since 1989
Driven by earlier detection, targeted therapy, and awareness — but progress has slowed since 2013.
4.3M
US survivors today
Living with or beyond a breast cancer diagnosis. Projected to exceed 5M by 2030.
+40%
Black mortality gap
Black women are 40% more likely to die despite ~5% lower incidence. The sharpest racial gap in US cancer.
76%
Women ≥40 ever screened
BRFSS 2022. Below the Healthy People 2030 target of 80%.
~10%
Hereditary cases
5–10% carry a BRCA1/2 or other high-risk mutation — underscreened in most primary care.
2.3M
Global new cases / yr
Most common cancer in women worldwide. Rising fastest in low- and middle-income countries.
685K
Global deaths / yr
WHO 2022. Survival rates vary 2-fold between high- and low-income countries.
$26B
Annual US care cost
Highest per-capita cost of any cancer in the US — before lost wages and caregiver burden.

Trends in Breast Cancer Care

Progress indicators and persistent gaps. National averages drawn from ACS Breast Cancer Facts & Figures 2024, CDC USCS, BRFSS, and HEDIS.

PHIT Score — Breast Cancer Sub-Indicator

This widget slots into the Women's Health Focus lens on the PHIT Score Card. The composite blends six metrics: incidence, mortality, screening rate, stage-at-dx, disparity gap, and survivorship support. Enter your ZIP below to see your county's score vs. state and national benchmarks.

📍
Find Your County's PHIT Breast Cancer Score
Enter your ZIP code to see how your county stacks up vs. your state and the national average
YOUR COUNTY
Enter ZIP above ↑
—
composite
Incidence · —
Mortality · —
Screening · —
Early-Stage Dx · —
Black mortality gap · —
STATE AVG
State (after lookup)
—
composite
Incidence · —
Mortality · —
Screening · —
Early-Stage Dx · —
Black mortality gap · —
NATIONAL AVG
United States
72
composite
Incidence · 128 per 100K
Mortality · 19.4 per 100K
Screening · 76%
Early-Stage Dx · 65%
Black mortality gap · +40% vs White
🎀 Breast Cancer NEW
National average composite score · methodology
Higher = better outcomes. Composite weights: incidence (15%), mortality (25%), screening (20%), stage-at-dx (15%), racial disparity gap (15%), survivorship support (10%). Source: CDC USCS, BRFSS, SEER, age-adjusted to 2000 US standard.
Incidence (all women)
128
per 100K, age-adj
Mortality (all women)
19.4
per 100K, age-adj
Screening Rate (≥40)
76%
past-2-yr mammogram
Early-Stage Dx
65%
localized at dx
Black Mortality Gap
+40%
vs White women
Survivors / Community
Variable
support-group density

Learn It — VIVA Video & Interactive Screening Walk-Through

Two ways to understand what's happening inside the body, without the jargon. The VIVA Breast Cancer video explains the biology in plain language; the interactive walk-through lets you step through a screening mammogram one frame at a time.

🎬 VIVA Breast Cancer — The Biology Video · 6 min
VIVA Breast Cancer
[Video embed pending port from legacy system]

A plain-language animated explainer walking through how breast cancer starts, how it spreads, and why early detection matters. Built for patients, students, and families — no medical degree required.

Watch the VIVA Video →
🩻 Interactive Mammography Walk-Through Interactive · 8 steps
Step-through Screening
[Interactive module — porting from legacy system]

Click through a mammography screening — arrival, positioning, imaging, reading, follow-up — so there are no surprises. Same pattern as the FFH Interactive Colonoscopy. Reduces fear, increases follow-through.

1Scheduling & prep
2Arrival & check-in
3Positioning
4Imaging (2D/3D)
5Radiologist reading
6Results & BI-RADS
7Follow-up imaging
8Biopsy (if needed)
Launch the Walk-Through →

Wellness & Recovery Power Partner — Cancer Exercise Training Institute (CETI)

When the diagnosis happens, the body changes. Exercise during and after treatment is one of the most evidence-based interventions for breast cancer recovery — but most personal trainers, physical therapists, and group fitness instructors aren't certified to work safely with cancer survivors. That's the gap CETI has filled for over 20 years. We're proud to align with them as the Wellness & Recovery Power Partner of My PinkPOWER Club.

⭐ POWER PARTNER · WELLNESS & RECOVERY

Cancer Exercise Training Institute

Founded 2004 · Andrea Leonard, Founder & President · cancerexercisetraininginstitute.com

Andrea Leonard built CETI on her own front-line experience. A thyroid cancer survivor whose mother walked through breast cancer, Andrea has spent two decades building the most respected oncology-exercise certification body in the United States — training fitness professionals to safely and effectively work with cancer survivors at every stage of treatment and recovery.

CETI's certifications are recognized by the American College of Sports Medicine (ACSM), NASM, AFAA, and ACE. Their distance-learning model on Teachable means certifications are accessible to fitness professionals nationwide — and globally.

CETI's 4 Certification Paths
1. Cancer Exercise Specialist (foundational)
2. Cancer Exercise Specialist Advanced
3. Breast Cancer Recovery BCRS · direct fit for My PinkPOWER Club
4. Master Trainer / Educator Pathway
Hosted on Teachable LMS — distance-learning model
🤝 PROPOSED INTEGRATION

CETI × Force for Health Certified Coach Pathway

FFH proposes to weave CETI's Cancer Exercise certifications directly into the Force for Health Certified Coach Pathway — making CETI an officially recognized specialty within the FFH coaching family. Two integration models on the table for tomorrow's discussion:

Model A · White-Label Specialty
FFH-Branded Cancer Exercise Track

CETI curriculum delivered under the FFH Certified Coach umbrella. Co-branded as "FFH Certified Cancer Exercise Coach — powered by CETI." Revenue share to CETI per enrollment.

Model B · Partnered Pathway
CETI Recognized as FFH Specialty

CETI keeps full brand identity. FFH credits CETI cert toward its own Coach Pathway. Co-marketing + cross-promotion. Rev share on FFH-driven referral enrollments.

The grants angle: As FFH approaches state-level partners (AZ AHCCCS, OEO, ADHS) for Rural Health Transformation and statewide subscription deployments, CETI gets written into the workforce-pillar line items as the certifying body for Cancer Exercise specialists in rural communities. State workforce dollars + RHT workforce pillar funding flow through to CETI enrollments. Mutual lift.
20+ yrs
Industry leader · founded 2004
4 paths
Foundation → Master Trainer
ACSM
Recognized · plus NASM, AFAA, ACE
Survivor-led
Andrea — thyroid; mother — breast cancer
Where CETI fits across the cancer dashboard family: CETI's expertise is not breast-cancer-only. As FFH builds out parallel dashboards for colon cancer (My BlueShield Club), prostate, ovarian, pediatric, and other cancers, CETI's Cancer Exercise Specialist certifications support survivors across every diagnosis. One partnership · multi-cancer reach · same revenue mechanic across every page.

Partners

My PinkPOWER Club is stronger because of the organizations standing with us. Partners power prevention, screening access, research, survivorship, and the My Girl Power™ Series community.

LFF
⭐ Power Foundational Partner

Larry Fitzgerald Foundation

The Larry Fitzgerald Foundation has been a pioneering voice for breast cancer awareness and patient support for more than two decades — building community around prevention, treatment access, and the families who walk the journey. We are honored to stand together on My PinkPOWER Club.

Cancer Exercise Training Institute (CETI)
⭐ Wellness & Recovery Power Partner
The Force for Health Academy Foundation
Fiscal Home · Scholarships
Arizona Chamber of Health
Community Activation
Your Organization
Open · Partner Invitation

Wrap your arms around My PinkPOWER Club

Sponsor a club, host a screening drive, fund a survivor scholarship, or bring My PinkPOWER Club and the Fit Family FORCE Ambassador Challenge to your community through The Force for Health Academy Foundation.

Partner With Us →

Data Sources

  1. American Cancer Society — Breast Cancer Facts & Figures 2024
  2. CDC — United States Cancer Statistics (USCS)
  3. NCI SEER — Cancer Stat Facts: Female Breast Cancer
  4. CDC Behavioral Risk Factor Surveillance System (BRFSS) — Mammography Rates
  5. USPSTF — Breast Cancer Screening Recommendations (2024)
  6. IARC GLOBOCAN — Global Cancer Incidence and Mortality
  7. WHO — Breast Cancer Fact Sheet
  8. National Breast Cancer Foundation
  9. NCBI — BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer Syndrome
  10. Susan G. Komen — Breast Cancer Statistics

Note on state-level estimates: State incidence, mortality, and screening rates use CDC USCS and BRFSS age-adjusted data (most recent 5-year pooled values). Individual years may differ. Rates are directional for this public overview; clinical and policy decisions should use the full CDC/SEER datasets linked above.